Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab for Carotid Plaque (SLICE-CEA)
NCT04539223Phase 4Unknown
- Sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Start
- Aug 2020
- Primary completion
- Apr 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in carotid artery stenosis (CAS), sponsored by Canadian Medical and Surgical Knowledge Translation Research Group. Status: unknown.
02
Drugs
evolocumab
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT04539223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539223.